Home | Welcome to Contract Pharma   
Last Updated Thursday, October 23 2014
Print

Breaking News

Gil Roth
January 7, 2014
Alitair, Celgene, Erytech, Galena, Neurocrine, Orexigen, Shield, TeaRx  Read More »
Kristin Brooks
January 6, 2014
Launches RSV Corp. to develop virosome vaccine technology  Read More »
Kristin Brooks
January 6, 2014
Enloe to lead strategic growth efforts  Read More »
Kristin Brooks
January 6, 2014
Gains cell biology and cell therapy R&D technologies  Read More »
Kristin Brooks
January 6, 2014
Straube to oversee clinical research programs  Read More »
Kristin Brooks
January 6, 2014
ANI to provide commercial manufacturing services   Read More »
Kristin Brooks
January 6, 2014
Wooster brings extensive oncology experience  Read More »
Gil Roth
January 6, 2014
Alkermes, DiaVacs, Kala, Oxygen Biotherpeutics, Peregrine, TauRx  Read More »
Kristin Brooks
January 3, 2014
Allows researchers to access sponsor clinical data  Read More »
Kristin Brooks
January 3, 2014
Alexar Therapeutics to develop portfolio of Liver X receptor (LXR) agonists  Read More »
Kristin Brooks
January 3, 2014
Mirna gains additional rights to lead program  Read More »
Kristin Brooks
January 3, 2014
Expands development and manufacturing for cell therapy product portfolio  Read More »
Kristin Brooks
January 3, 2014
Lead molecule and back-up compounds offer potential in cancer/inflammatory diseases  Read More »
Kristin Brooks
January 3, 2014
Ranker and Ho join the board  Read More »
Kristin Brooks
January 3, 2014
Bamzai to head commercial ops in India  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On